These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17435619)
1. Case files from Stanford University Medical Center: ten years of HAART: a long wait for full HIV suppression. Shulman N; Shafer RW MedGenMed; 2007 Jan; 9(1):10. PubMed ID: 17435619 [No Abstract] [Full Text] [Related]
2. [Antiretroviral therapy in 2004]. Jablonowski H MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049 [TBL] [Abstract][Full Text] [Related]
3. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors. Jones R; Gazzard B Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210 [TBL] [Abstract][Full Text] [Related]
4. Managing HIV/AIDS patients. Paul SM; Sensakovic J; Podhurst LS; Morgan DH; Triano-Davis W N J Med; 1998 May; 95(5):55-60. PubMed ID: 16013158 [No Abstract] [Full Text] [Related]
5. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181 [TBL] [Abstract][Full Text] [Related]
6. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'. Hastings IM; Lalloo DG; Khoo SH AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825 [No Abstract] [Full Text] [Related]
7. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M; HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546 [No Abstract] [Full Text] [Related]
8. Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease. Leng LK; Pancharoen C; Bunupuradah T; Thisyakorn U; Trinavarat P; Sosothikul D; Ananworanich J J Med Assoc Thai; 2007 Sep; 90(9):1937-42. PubMed ID: 17957942 [TBL] [Abstract][Full Text] [Related]
9. German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Salzberger B; Marcus U; Vielhaber B; Arasteh K; Gölz J; Brockmeyer NH; Rockstroh J Eur J Med Res; 2004 Nov; 9(11):491-504. PubMed ID: 15649858 [TBL] [Abstract][Full Text] [Related]
10. HAART improves quality of life: should we care about the quality of spermatozoa? Vernazza P AIDS; 2008 Mar; 22(5):647-8. PubMed ID: 18317007 [No Abstract] [Full Text] [Related]
11. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946 [TBL] [Abstract][Full Text] [Related]
12. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study. Poggensee G; Kücherer C; Werning J; Somogyi S; Bieniek B; Dupke S; Jessen H; Hamouda O; HIV Med; 2007 Nov; 8(8):511-9. PubMed ID: 17944684 [TBL] [Abstract][Full Text] [Related]
13. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873 [No Abstract] [Full Text] [Related]
14. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200 [TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981 [TBL] [Abstract][Full Text] [Related]
17. Combination antiretroviral therapy failure and HIV super-infection. Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235 [TBL] [Abstract][Full Text] [Related]
18. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088 [TBL] [Abstract][Full Text] [Related]
19. [Antiretroviral therapies: strategic perspectives for the future]. Reynes J Med Trop (Mars); 2007 Aug; 67(4):367. PubMed ID: 17926796 [No Abstract] [Full Text] [Related]
20. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)]. ; Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554 [No Abstract] [Full Text] [Related] [Next] [New Search]